Previous Close | 77.08 |
Open | 77.22 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 1000 |
Day's Range | 76.97 - 78.87 |
52 Week Range | 52.60 - 81.78 |
Volume | |
Avg. Volume | 563,106 |
Market Cap | 7.974B |
Beta (5Y Monthly) | 1.04 |
PE Ratio (TTM) | 77.81 |
EPS (TTM) | 1.01 |
Earnings Date | Feb 15, 2023 - Feb 20, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 71.79 |
AUDUBON, Pa., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Tuesday, February 21, 2023. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment
Investors are optimistic about Globus Medical's (GMED) robust performance across several international markets.
In this article, we will take a look at the 15 largest orthopedic companies in the world. If you want to see more companies in this selection, go to the 5 Largest Orthopedic Companies in the World. The orthopedic industry has staged a comeback in the last two years following a dismal 2020 due to […]